Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.

Autor: Liu, Yansong1 (AUTHOR), Li, Mingcui1 (AUTHOR), Fang, Zhengbo1 (AUTHOR), Gao, Shan2 (AUTHOR), Cheng, Weilun1 (AUTHOR), Duan, Yunqiang1 (AUTHOR), Wang, Xuelian1 (AUTHOR), Feng, Jianyuan1 (AUTHOR), Yu, Tianshui1 (AUTHOR), Zhang, Jiarui1 (AUTHOR), Wang, Ting1 (AUTHOR), Hu, Anbang1 (AUTHOR), Zhang, Hanyu1 (AUTHOR), Rong, Zhiyuan1 (AUTHOR), Shakila, Suborna S.1 (AUTHOR), Shang, Yuhang1 (AUTHOR), Kong, Fanjing1 (AUTHOR), Liu, Jiangwei1 (AUTHOR), Li, Yanling1 (AUTHOR) liyanling1016@163.com, Ma, Fei1 (AUTHOR) wafsfd@sina.com
Zdroj: Cancer Immunology, Immunotherapy. Jul2024, Vol. 73 Issue 7, p1-15. 15p.
Databáze: Academic Search Ultimate
Externí odkaz: